Pages that link to "Item:Q4230628"

The following pages link to Drug concentration heterogeneity facilitates the evolution of drug resistance (Q4230628):

Displaying 47 items.

• Stochastic modelling of viral blips in HIV-1-infected patients: effects of inhomogeneous density fluctuations (Q300906) (← links)
• Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy (Q329368) (← links)
• A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals (Q345447) (← links)
• The role of backward mutations on the within-host dynamics of HIV-1 (Q378292) (← links)
• Role of \(CD4^{+}\) T-cell proliferation in HIV infection under antiretroviral therapy (Q442473) (← links)
• Complete classification of global dynamics of a virus model with immune responses (Q478241) (← links)
• Global stability and backward bifurcation of a general viral infection model with virus-driven proliferation of target cells (Q478668) (← links)
• Permanence and extinction of a non-autonomous HIV-1 model with time delays (Q478670) (← links)
• Impact of latently infected cells on strain archiving within HIV hosts (Q692472) (← links)
• Viral infection in internally structured hosts. I: Conditions for persistent infection (Q776536) (← links)
• Reservoir interactions and disease emergence (Q935954) (← links)
• Stability analysis of delay differential equation models of HIV-1 therapy for fighting a virus with another virus (Q1018669) (← links)
• Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity (Q1405284) (← links)
• Mathematical analysis of delay differential equation models of HIV-1 infection (Q1614064) (← links)
• The amplitudes of viral blips in HIV-1 infected patients treated with antiretroviral therapy are power-law distributed (Q1617612) (← links)
• Modeling HIV persistence, the latent reservoir, and viral blips (Q1625882) (← links)
• Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV (Q1661641) (← links)
• Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (Q1788684) (← links)
• Modeling interleukin-2-based immunotherapy in AIDS pathogenesis (Q1790721) (← links)
• An in-depth analysis of the HIV-1/AIDS dynamics by comprehensive mathematical modeling (Q1930947) (← links)
• Within-host viral dynamics in a multi-compartmental environment (Q2008277) (← links)
• A diffusive virus model with a fixed intracellular delay and combined drug treatments (Q2047168) (← links)
• Stochastic investigation of HIV infection and the emergence of drug resistance (Q2130165) (← links)
• Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative (Q2130784) (← links)
• Modelling the dynamics of LCMV infection in mice. II: Compartmental structure and immunopathology (Q2177125) (← links)
• Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment (Q2177143) (← links)
• Optimizing within-host viral fitness: infected cell lifespan and virion production rate (Q2189284) (← links)
• Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility (Q2219787) (← links)
• The logistic growth model as an approximating model for viral load measurements of influenza a virus (Q2229003) (← links)
• The effect of spatiotemporal antibiotic inhomogeneities on the evolution of resistance (Q2288471) (← links)
• Global stability analysis of HIV-1 infection model with three time delays (Q2346498) (← links)
• Emergence of HIV-1 drug resistance during antiretroviral treatment (Q2426347) (← links)
• Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects (Q2440890) (← links)
• Modeling the role of altruism of antibiotic-resistant bacteria (Q2447553) (← links)
• Global dynamics of a delay virus model with recruitment and saturation effects of immune responses (Q2628142) (← links)
• Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense (Q2693576) (← links)
• Global stability of a discrete virus dynamics model with Holling type-II infection function (Q2814070) (← links)
• Spatial Aspects of HIV Infection (Q2820372) (← links)
• DYNAMICAL MODEL OF IN-HOST HIV INFECTION: WITH DRUG THERAPY AND MULTI VIRAL STRAINS (Q2871162) (← links)
• A mathematical model for HIV treatment with time-varying antiretroviral therapy (Q2885546) (← links)
• Dynamics of an HIV-1 therapy model of fighting a virus with another virus (Q3186347) (← links)
• Global dynamics of a two-strain HIV infection model with intracellular delay (Q5040145) (← links)
• Linking within- and between-host scales for understanding the evolutionary dynamics of quantitative antimicrobial resistance (Q6070688) (← links)
• Modeling antiretrovial treatment to mitigate HIV in the brain: impact of the blood-brain barrier (Q6078303) (← links)
• Time-adaptive determination of drug efficacy in mathematical model of HIV infection (Q6144616) (← links)
• Counterintuitive properties of evolutionary measures: a stochastic process study in cyclic population structures with periodic environments (Q6174176) (← links)
• Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate (Q6192816) (← links)